242 related articles for article (PubMed ID: 21303731)
1. Deficits in GABA(B) receptor system in schizophrenia and mood disorders: a postmortem study.
Fatemi SH; Folsom TD; Thuras PD
Schizophr Res; 2011 May; 128(1-3):37-43. PubMed ID: 21303731
[TBL] [Abstract][Full Text] [Related]
2. Protein expression of targets of the FMRP regulon is altered in brains of subjects with schizophrenia and mood disorders.
Folsom TD; Thuras PD; Fatemi SH
Schizophr Res; 2015 Jul; 165(2-3):201-11. PubMed ID: 25956630
[TBL] [Abstract][Full Text] [Related]
3. Expression of GABAA α2-, β1- and ε-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder.
Fatemi SH; Folsom TD; Rooney RJ; Thuras PD
Transl Psychiatry; 2013 Sep; 3(9):e303. PubMed ID: 24022508
[TBL] [Abstract][Full Text] [Related]
4. mRNA and protein expression for novel GABAA receptors θ and ρ2 are altered in schizophrenia and mood disorders; relevance to FMRP-mGluR5 signaling pathway.
Fatemi SH; Folsom TD; Rooney RJ; Thuras PD
Transl Psychiatry; 2013 Jun; 3(6):e271. PubMed ID: 23778581
[TBL] [Abstract][Full Text] [Related]
5. GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism.
Fatemi SH; Folsom TD
Schizophr Res; 2015 Sep; 167(1-3):42-56. PubMed ID: 25432637
[TBL] [Abstract][Full Text] [Related]
6. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders.
Beneyto M; Kristiansen LV; Oni-Orisan A; McCullumsmith RE; Meador-Woodruff JH
Neuropsychopharmacology; 2007 Sep; 32(9):1888-902. PubMed ID: 17299517
[TBL] [Abstract][Full Text] [Related]
7. GABA
Fatemi SH; Folsom TD; Thuras PD
Synapse; 2017 Jul; 71(7):. PubMed ID: 28316115
[TBL] [Abstract][Full Text] [Related]
8. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum.
Fatemi SH; Stary JM; Earle JA; Araghi-Niknam M; Eagan E
Schizophr Res; 2005 Jan; 72(2-3):109-22. PubMed ID: 15560956
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Neurosci Lett; 2005 Aug; 383(3):272-7. PubMed ID: 15955420
[TBL] [Abstract][Full Text] [Related]
10. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.
Guidotti A; Auta J; Davis JM; Di-Giorgi-Gerevini V; Dwivedi Y; Grayson DR; Impagnatiello F; Pandey G; Pesold C; Sharma R; Uzunov D; Costa E
Arch Gen Psychiatry; 2000 Nov; 57(11):1061-9. PubMed ID: 11074872
[TBL] [Abstract][Full Text] [Related]
11. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium.
Uranova NA; Vostrikov VM; Orlovskaya DD; Rachmanova VI
Schizophr Res; 2004 Apr; 67(2-3):269-75. PubMed ID: 14984887
[TBL] [Abstract][Full Text] [Related]
12. M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders.
Zavitsanou K; Katsifis A; Yu Y; Huang XF
Brain Res Bull; 2005 May; 65(5):397-403. PubMed ID: 15833594
[TBL] [Abstract][Full Text] [Related]
13. Expression of PSA-NCAM and synaptic proteins in the amygdala of psychiatric disorder patients.
Varea E; Guirado R; Gilabert-Juan J; Martí U; Castillo-Gomez E; Blasco-Ibáñez JM; Crespo C; Nacher J
J Psychiatr Res; 2012 Feb; 46(2):189-97. PubMed ID: 22099865
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients.
Bullock WM; Cardon K; Bustillo J; Roberts RC; Perrone-Bizzozero NI
Am J Psychiatry; 2008 Dec; 165(12):1594-603. PubMed ID: 18923069
[TBL] [Abstract][Full Text] [Related]
15. The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders.
Nudmamud-Thanoi S; Reynolds GP
Neurosci Lett; 2004 Nov; 372(1-2):173-7. PubMed ID: 15531111
[TBL] [Abstract][Full Text] [Related]
16. Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders.
Thompson Ray M; Weickert CS; Wyatt E; Webster MJ
J Psychiatry Neurosci; 2011 May; 36(3):195-203. PubMed ID: 21223646
[TBL] [Abstract][Full Text] [Related]
17. NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder.
Toro C; Deakin JF
Schizophr Res; 2005 Dec; 80(2-3):323-30. PubMed ID: 16140506
[TBL] [Abstract][Full Text] [Related]
18. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins.
Eastwood SL; Harrison PJ
Brain Res Bull; 2001 Jul; 55(5):569-78. PubMed ID: 11576753
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of muscarinic receptors in psychiatric disorders: a focus on schizophrenia and mood disorders.
Dean B; Scarr E
Curr Mol Med; 2015; 15(3):253-64. PubMed ID: 25817858
[TBL] [Abstract][Full Text] [Related]
20. Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics.
Marx CE; Stevens RD; Shampine LJ; Uzunova V; Trost WT; Butterfield MI; Massing MW; Hamer RM; Morrow AL; Lieberman JA
Neuropsychopharmacology; 2006 Jun; 31(6):1249-63. PubMed ID: 16319920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
